Sun Pharma Q3 Results: Drug major beats analysts' estimates with 5% rise in profit

Sun Pharma Q3 Results: The pharmaceutical major reported a 5.2 per cent year-on-year increase in net profit to Rs 2,166 crore for the quarter ended December 2022.

Sun Pharma Q3 Results: Drug major beats analysts' estimates with 5% rise in profit
Sun Pharma reported a consolidated net profit of Rs 2,166 crore for the quarter ended December 2022. | Image: Reuters

Sun Pharma on Tuesday reported a net profit of Rs 2,166 crore for the quarter ended December 2022, marking an increase of 5.2 per cent compared with the corresponding period a year ago. 

Its revenue came in at Rs 11,241 crore for the three-month period, up 14 per cent on a year-on-year basis.

According to Zee Business research, Sun Pharma's quarterly net profit was estimated at Rs 2,019 crore, revenue at Rs 11,078 crore and margin at 26 per cent. 

Sun Pharma's board approved an interim dividend of Rs 7.5 per share.

(This story will be updated shortly)

Catch LIVE stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

RECOMMENDED STORIES

https://www.zeebiz.com/personal-finance/photo-gallery-epfo-retirement-pension-scheme-early-pension-superannuation-disablement-widow-child-orphan-pension-online-login-passbook-employee-provident-fund-327598

EPFO Pension Schemes: Early pension, retirement pension, nominee pension and 4 other pension schemes that every private sector employee should know

https://www.zeebiz.com/trending/news-rains-in-tamil-nadu-orange-alert-issues-for-november-26-regional-meteorological-centre-cyclone-south-andaman-sea-puducherry-karaikkal-327505

Tamil Nadu Weather News: Heavy rain likely in TN, orange alert issued for Nov 26

https://www.zeebiz.com/markets/stocks/photo-gallery-psu-and-largecap-shares-to-buy-short-term-bse-sensex-nse-nifty-pick-of-the-day-327460

Stocks to buy: Hindustan Aeronautics, Zomato, Tata Tech, GMR Airports among analysts' top picks

https://www.zeebiz.com/trending/photo-gallery-delhi-aqi-today-air-pollution-level-falls-to-very-poor-quality-schools-closed-work-from-home-started-in-office-government-bans-firecrackers-sale-on-ecommerce-sites-city-records-lowest-temperature-327481

Delhi AQI Today: Air quality index level drops; city records season's lowest temperature

https://www.zeebiz.com/market-news/news-tata-motors-muthoot-finance-crisil-stocks-to-buy-axis-direct-bse-nse-327646

Tata Motors, Muthoot Finance and 3 more: Axis Direct recommends buying these stocks for 2 weeks; check targets, stop losses

https://www.zeebiz.com/markets/stocks/photo-gallery-largecap-psu-stock-power-grid-share-price-target-nse-bse-acquires-khavda-v-a-power-transmission-project-327494

120% return in 3 years: Largecap PSU stock gains as company announces acquisition - Do you own?

https://www.zeebiz.com/markets/stocks/photo-gallery-10-stocks-to-buy-under-rs-500-psu-largecap-midcap-smallcap-nse-nifty-bse-sensex-327566

Need Stocks to Buy Under Rs 500? Analysts bullish on 10 scrips for long term

https://www.zeebiz.com/personal-finance/photo-gallery-top-5-small-cap-mutual-funds-with-best-sip-xirr-returns-in-1-year-calculator-inr-rs-25000-monthly-investment-has-grown-to-355000-nifty-150-tri-bse-invesco-edelweiss-hsbc-franklin-nav-aum-327419

Top 5 Small Cap Mutual Funds with best SIP returns in 1 year: See how Rs 25,000 monthly investment has grown in each scheme

https://www.zeebiz.com/personal-finance/photo-gallery-top-7-sbi-sip-mutual-funds-with-highest-sip-return-xirr-in-1-year-capital-gains-calculator-how-inr-rs-25000-monthly-investment-has-grown-to-bse-sp-nifty-multi-large-health-tech-banking-326674

Top 7 SBI Mutual Funds With Best SIP Returns in 1 Year: Rs 25,000 monthly SIP investment in No.1 fund has jumped to Rs 3,58,404

Written By: PTI
Updated: Tue, Jan 31, 2023
02:30 PM IST
New Delhi, ZeeBiz WebDesk
RELATED NEWS
Sun Pharma drops 5% after US court halts launch of alopecia treatment drug Sun Pharma drops 5% after US court halts launch of alopecia treatment drug
Sun Pharma Q2 Results Preview: PAT likely to grow 11.5%; gross margin may improve Sun Pharma Q2 Results Preview: PAT likely to grow 11.5%; gross margin may improve

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x